Skip to main content

Cavidi Selected to Present at Cavendish Global Health Impact Forum

Press Release   •   Feb 15, 2016 09:08 GMT

Stockholm 15th February 2016 — Cavidi a specialist HIV monitoring company, announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place February 15th to February 18th at the Breakers in Palm Beach, Florida. The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish this mission, the Forum showcases presentations and panel discussions by leading family offices, accomplished foundations, research institutions, and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. A unique gathering of family offices, Cavendish Impact Forums are hosted by leading institutions around the world and take place three times each year.

Michael Moffat, Cavendish co-founder and Chief Executive Officer explains, “The theme of our Palm Beach Forum is a ‘Celebration of Philanthropy, Impact Investing and Innovation that is Changing the World.’ With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organizations that meet the required standard of excellence. The quality and originality of Cavidi research and scientific insights in HIV Viral Load, positions them to make a major contribution to the effective treatment of HIV and a reduction in the further spread of the disease. ”

“We are honored to be selected to present at this unique event, and it is further recognition of our innovative approach to the monitoring of HIV that is afflicting populations around the world today,” said John Reisky de Dubnic CEO of Cavidi. “We welcome the chance to interact with many of world’s most accomplished scientists, thought-leaders and generous philanthropic individuals and families who are all dedicated to the common cause of improving the health and lives of people around the world.”

Cavendish Global consists of over 200 leading family offices and foundations from around the world with combined assets of over $260 billion who share a passion for pro-social endeavors within health and the life sciences. The Cavendish Global Health Impact Forum provides family offices with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the information and educational resources required by foundations actively seeking to accelerate technological innovation and health access through sustainable philanthropy, grant-making and impact investing. The Forum is also an opportunity for family offices to champion and share information on projects and organizations, which they are passionate about with other family offices from around the world.

About Cavidi

Cavidi is a leading Swedish supplier of diagnostics for HIV monitoring. Cavidi’s products enable efficient management of anti-HIV drugs (ARV therapy) so that people living with HIV can lead a normal productive life. Cavidi’s diagnostics reduce the cost of treatment and improve the efficacy of HIV care. Cavidi is a Swedish biotech company with its head office in Uppsala and sales offices in South Africa, India and USA.

Further information is available on the Company's website www.cavidi.com

About Cavendish Global

(http://cavendishglobal.com)

Cavendish Global provides family offices and their foundations with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the innovative resources required to help develop and implement their individual pro-social impact investment and philanthropy programs within health and the life sciences. Cavendish Global provides family offices with a number of innovative resources, which includes Cavendish Impact Forums. A unique gathering of leading family offices, Cavendish Impact Forums take place three times each year.


For more information: http://cavendishglobal.com


For Further Information Contact:

Alex Charlton President, Cavendish Global alex.charlton@cavendishglobal.com

Tel: +1-917-576-1435

For over two decades Cavidi has been dedicated to increasing access to HIV viral load monitoring for all HIV-positive patients. Our ExaVir™ Load test accomplishes this by bringing national reference lab quality to the nearpatient environment. Independent studies confirm that ExaVir Load is as accurate as gold standard RNA-based tests yet is capable of running in virtually any lab. In fact, ExaVir Load is proven to perform at the District Hospital level where the need is greatest. 

To date, over 400,000 ExaVir Load tests have been run backed by governments and major global NGOs in more than 25 countries. But there is still much work to be done. Cavidi is committed to continued innovation in this area in support of our conviction that the time for HIV viral load testing is now

Comments (0)

Add comment

Comment